The WACC of Blueberries Medical Corp (BBM.CN) is 5.9%.
Range | Selected | |
Cost of equity | 5.1% - 6.7% | 5.9% |
Tax rate | 25.9% - 26.5% | 26.2% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 5.0% - 6.7% | 5.9% |
Category | Low | High |
Long-term bond rate | 3.2% | 3.7% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.37 | 0.42 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.1% | 6.7% |
Tax rate | 25.9% | 26.5% |
Debt/Equity ratio | 0 | 0 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 5.0% | 6.7% |
Selected WACC | 5.9% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
BBM.CN | Blueberries Medical Corp | 0 | -3.12 | -3.11 |
BSEM | Biostem Technologies Inc | 0.02 | 1.96 | 1.93 |
CPMD | CannaPharmaRx Inc | 2.16 | -1.06 | -0.41 |
KAYS | Kaya Holdings Inc | 5.62 | 0.44 | 0.09 |
KOAN | Resonate Blends Inc | 27.07 | 0.55 | 0.03 |
MJ.CN | True Leaf Brands Inc | 8.68 | 1.01 | 0.14 |
MMJ.CN | Matica Enterprises Inc | 0.17 | 1.15 | 1.02 |
PVCT | Provectus Biopharmaceuticals Inc | 0.09 | 0.13 | 0.12 |
SUGR.V | SugarBud Craft Growers Corp | 1.21 | 0.6 | 0.32 |
THC.CN | THC Biomed Intl Ltd | 2.74 | -0.29 | -0.09 |
Low | High | |
Unlevered beta | 0.06 | 0.13 |
Relevered beta | 0.06 | 0.13 |
Adjusted relevered beta | 0.37 | 0.42 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BBM.CN:
cost_of_equity (5.90%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (0.37) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.